Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

CAPS Rating: 5 out of 5

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

Recs

1
Player Avatar as10675 (98.33) Submitted: 8/5/2012 6:31:56 PM : Outperform Start Price: $42.38 TEVA Score: -25.23

Yield 2.46%. DGR 18%. PE 11. Normal PE 19. EPS Growth 21%. 13 year Dividend Contender. Undervalued. Position held in Brokerage account. Reinvesting dividends. Intend to increase position using cash dividend payouts from other stocks and new investment funds.

Featured Broker Partners


Advertisement